Underprescribing in Geriatric Patients: a Prevalence Study and Analysis of Factors Contributing to Potential Prescription Omissions (Under-PRES)

ConditionOlder People
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorIstituto Nazionale di Ricovero e Cura per Anziani

About this trial

This observational study will determine the prevalence of underprescription in a cohort of elderly patients, recruited at the time of an outpatient geriatric visit, or hospitalized, upon admission to a geriatric ward.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Geriatric ward admission or outpatient geriatric appointment

Capacity to provide informed consent by the patient or legal guardian

Disqualifiers

Limited life expectancy as measured by the Clinical Frailty Scale (CFS) >8

Trial population

Older patients at admission to a geriatric ward or at the time of outpatient geriatric visits

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

374 Participants
are grouped into 1 trial group
Group A: older adults

Trial outcomes

Primary outcomes

1

Rate of potential prescription omissions (PPOs)

Prevalence of potential prescription omissions (PPOs) will be evaluated by Screening Tool to Alert doctors to Right Treatment (START) criteria version 3 in aged patients enrolled on admission to geriatric departments of participating centers or during geriatric outpatient clinic visits

Time frame
at baseline and 3 months later

Secondary outcomes

1

Characterisation of the potential prescription omissions (PPOs)

The reasons for underprescription will be investigated to differentiate between justified and inappropriate potential prescriptive omissions (PPOs). Patients and/or their family members and/or the general practitioner will be interviewed to assess the potential reasons related to underprescription.

Time frame
at baseline and 3 months later

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.